Arcturus Therapeutics Holdings Inc
ARCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$431.75M
Close$
$-5.26
131.4% downside
Current Fair Value
131.4% downsideOvervalued by 131.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $431.75 Million |
|---|---|
| Enterprise Value | $269.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.4 |
| Beta | 2.27 |
| Outstanding Shares | 28,423,000 |
Return
| Return on Equity | -37.47% |
|---|---|
| Return on Assets | -28.70% |
| Return on Invested Capital | -51.89% |
Valuation & Multiples
| P/E Ratio | -4.56 |
|---|---|
| PEG | -2.87 |
| Price to Sales | - |
| Price to Book Ratio | 2.79 |
| Enterprise Value to Revenue | 14.69 |
| Enterprise Value to EBIT | -2.72 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-1.07
Average shareholder expectationRevenue Estimate
$3.11 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.67
Average shareholder expectationRevenue Estimate
$8.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.5688▲ 77.09% |
|---|---|
| Total Calls | 12,621▼ 94.40% |
| Total Puts | 19,800▼ 88.98% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.73%▲ 3.27% |
|---|---|
| Total Invested | $169.83M▼ 9.34% |
| Investors Holding | 139▲ 9.00% |
ESG Score
No data